The use of demethylating agents to re-express DKK3 in cancers where promoter hypermethylation leads to gene silencing have been shown in studies using cell lines of several cancers including gastric, prostate, lung, and leukemia (reviewed by Veeck and Dahl, 2012). The gene discussed is DKK3; the disease is leukemia.